JP2020500215A5 - - Google Patents

Download PDF

Info

Publication number
JP2020500215A5
JP2020500215A5 JP2019545725A JP2019545725A JP2020500215A5 JP 2020500215 A5 JP2020500215 A5 JP 2020500215A5 JP 2019545725 A JP2019545725 A JP 2019545725A JP 2019545725 A JP2019545725 A JP 2019545725A JP 2020500215 A5 JP2020500215 A5 JP 2020500215A5
Authority
JP
Japan
Prior art keywords
ring
alkyl
aliphatic
rings
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019545725A
Other languages
English (en)
Japanese (ja)
Other versions
JP7199364B2 (ja
JP2020500215A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/060305 external-priority patent/WO2018089330A2/en
Publication of JP2020500215A publication Critical patent/JP2020500215A/ja
Publication of JP2020500215A5 publication Critical patent/JP2020500215A5/ja
Application granted granted Critical
Publication of JP7199364B2 publication Critical patent/JP7199364B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019545725A 2016-11-08 2017-11-07 sGC刺激剤 Active JP7199364B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662419086P 2016-11-08 2016-11-08
US62/419,086 2016-11-08
PCT/US2017/060305 WO2018089330A2 (en) 2016-11-08 2017-11-07 Sgc stimulators

Publications (3)

Publication Number Publication Date
JP2020500215A JP2020500215A (ja) 2020-01-09
JP2020500215A5 true JP2020500215A5 (cg-RX-API-DMAC7.html) 2020-12-17
JP7199364B2 JP7199364B2 (ja) 2023-01-05

Family

ID=60473639

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019545725A Active JP7199364B2 (ja) 2016-11-08 2017-11-07 sGC刺激剤

Country Status (12)

Country Link
US (2) US11180493B2 (cg-RX-API-DMAC7.html)
EP (1) EP3538520B1 (cg-RX-API-DMAC7.html)
JP (1) JP7199364B2 (cg-RX-API-DMAC7.html)
CN (1) CN110267949A (cg-RX-API-DMAC7.html)
AU (1) AU2017356887B2 (cg-RX-API-DMAC7.html)
CA (1) CA3042713A1 (cg-RX-API-DMAC7.html)
ES (1) ES3059583T3 (cg-RX-API-DMAC7.html)
IL (1) IL266372B2 (cg-RX-API-DMAC7.html)
MA (1) MA46755A (cg-RX-API-DMAC7.html)
PH (1) PH12019501017A1 (cg-RX-API-DMAC7.html)
SG (1) SG10202104876SA (cg-RX-API-DMAC7.html)
WO (1) WO2018089330A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017356887B2 (en) * 2016-11-08 2022-06-30 Cyclerion Therapeutics, Inc. sGC stimulators
KR102615821B1 (ko) 2017-04-11 2023-12-21 선샤인 레이크 파르마 컴퍼니 리미티드 불소-치환된 인다졸 화합물 및 이의 용도
MX2020003451A (es) 2017-10-31 2020-08-03 Hoffmann La Roche Sulfonas y sulfoxidos biciclicos y metodos de uso de los mismos.
US12220414B2 (en) * 2018-07-11 2025-02-11 Tisento Therapeutics Inc. Use of sGC stimulators for the treatment of mitochondrial disorders
CN113302193B (zh) 2019-01-11 2026-05-29 豪夫迈·罗氏有限公司 双环吡咯并三唑酮化合物及其使用方法
CN110305125B (zh) * 2019-06-06 2021-09-03 山东新华制药股份有限公司 5-嘧啶-6-氧-吡唑并吡啶类衍生物及其制备方法和应用
CN110669045A (zh) * 2019-09-05 2020-01-10 南通大学 一种1-甲基-[1,5-a]-吡啶并咪唑-3-腈及其化学合成方法
EP4472620A1 (en) 2022-02-01 2024-12-11 Charité - Universitätsmedizin Berlin A soluble guanylat cyclase activator for treating chronic vascular dysfunction
CN118772140B (zh) * 2023-04-07 2026-04-17 四川大学 一类化合物及其在治疗hDHODH介导的疾病中的用途

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3995631A (en) 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US4203440A (en) 1978-10-23 1980-05-20 Alza Corporation Device having variable volume chamber for dispensing useful agent
US4627850A (en) 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
DE3660408D1 (en) 1985-02-27 1988-08-25 Oerlikon Buehrle Ag Apparatus for measuring the vibrations of a spiral bevel gear transmission in a gear-testing machine
IL92966A (en) 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5324280A (en) 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5994341A (en) 1993-07-19 1999-11-30 Angiogenesis Technologies, Inc. Anti-angiogenic Compositions and methods for the treatment of arthritis
JP2928079B2 (ja) 1994-02-14 1999-07-28 永信薬品工業股▲ふん▼有限公司 1−(置換ベンジル)−3−(置換アリール)縮合ピラゾール類、その製造法及びその用途
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
DE19744026A1 (de) 1997-10-06 1999-04-08 Hoechst Marion Roussel De Gmbh Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
CZ302691B6 (cs) 1998-07-08 2011-09-07 Sanofi - Aventis Deutschland GmbH N-Arylamidová sloucenina, zpusob její prípravy, farmaceutický prostredek tuto slouceninu obsahující, tato sloucenina pro použití jako aktivátor a pro použití k terapii nebo profylaxi
DE19830430A1 (de) 1998-07-08 2000-01-13 Hoechst Marion Roussel De Gmbh Schwefelsubstituierte Sulfonylamino-carbonsäure-N-arylamide, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19834044A1 (de) 1998-07-29 2000-02-03 Bayer Ag Neue substituierte Pyrazolderivate
DE19834047A1 (de) 1998-07-29 2000-02-03 Bayer Ag Substituierte Pyrazolderivate
GB9824310D0 (en) 1998-11-05 1998-12-30 Univ London Activators of soluble guanylate cyclase
DE69915346T2 (de) 1998-12-17 2004-07-22 Alza Corp., Mountain View Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
DE19942809A1 (de) 1999-09-08 2001-03-15 Bayer Ag Verfahren zur Herstellung substituierter Pyrimidinderivate
DE19943635A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE10216145A1 (de) 2002-04-12 2003-10-23 Bayer Ag Verwendung von Stimulatoren der löslichen Guanylatcyclase zur Behandlung von Glaukom
DE10220570A1 (de) 2002-05-08 2003-11-20 Bayer Ag Carbamat-substituierte Pyrazolopyridine
DE10232572A1 (de) 2002-07-18 2004-02-05 Bayer Ag Neue 2,5-disubstituierte Pyrimidinderivate
CA2534371A1 (en) 2003-08-04 2005-02-10 Pfizer Products Inc. Dosage forms providing controlled release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors
DE102006020327A1 (de) 2006-04-27 2007-12-27 Bayer Healthcare Ag Heterocyclisch substituierte, anellierte Pyrazol-Derivate und ihre Verwendung
CN101939053A (zh) 2007-09-06 2011-01-05 默沙东公司 可溶性的鸟苷酸环化酶活化剂
CA2711134A1 (en) 2008-01-24 2009-07-30 Merck Sharp & Dohme Corp. Angiotensin ii receptor antagonists
CA2743864A1 (en) 2008-11-25 2010-06-10 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators
CA2753434C (en) 2009-02-26 2014-07-15 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators
US9284301B2 (en) 2010-03-25 2016-03-15 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators
UA107112C2 (uk) 2010-05-27 2014-11-25 Мерк Шарп Енд Доме Корп. Активатори розчинної гуанілатциклази
WO2012058132A1 (en) 2010-10-28 2012-05-03 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators
BR112014005110A2 (pt) 2011-09-02 2017-04-18 Bayer Ip Gmbh pirimidinas aneladas substituídas e utilização das mesmas
WO2014042263A1 (ja) 2012-09-14 2014-03-20 田辺三菱製薬株式会社 新規レニン阻害薬
ES2911276T3 (es) 2013-03-15 2022-05-18 Cyclerion Therapeutics Inc Estimuladores de sGC
CN105764893A (zh) 2013-10-30 2016-07-13 拜耳制药股份公司 杂芳基取代的吡唑
KR20180094965A (ko) * 2015-12-14 2018-08-24 아이언우드 파마슈티컬스, 인코포레이티드 위장 괄약근 기능장애의 치료를 위한 sGC 자극제의 용도
WO2017108441A1 (en) 2015-12-22 2017-06-29 Universiteit Maastricht Treatment of cognitive impairment with cgc stimulator
WO2017121700A1 (de) 2016-01-15 2017-07-20 Bayer Pharma Aktiengesellschaft 1,3-disubstituierte 1h-pyrazolo[3,4-b]pyridin- derivate und ihre verwendung als stimulatoren der löslichen guanylatcyclase
EP3538096B1 (en) * 2016-11-08 2024-02-28 Tisento Therapeutics Inc. Treatment of cns diseases with sgc stimulators
AU2017356887B2 (en) 2016-11-08 2022-06-30 Cyclerion Therapeutics, Inc. sGC stimulators

Similar Documents

Publication Publication Date Title
JP6629947B2 (ja) 高インスリン血症に関連した症状の処置
JP2011515482A5 (cg-RX-API-DMAC7.html)
EA023824B1 (ru) ПРОИЗВОДНЫЕ 3,4-ДИГИДРОПИРРОЛО[1,2-a]ПИРАЗИН-1-ИЛАМИНА, ПРИГОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ БЕТА-СЕКРЕТАЗЫ (BACE)
RU2007105350A (ru) 3-(гетероарилокси)-2-алкил-1-азабициклоалкильные производные, как лиганды альфа-7-nachr (никотиновых ацетилхолиновых рецепторов), предназначенные для лечения заболеваний центральной нервной системы
JP2018505898A5 (cg-RX-API-DMAC7.html)
CA2441565A1 (en) Bisarylamines as potassium channel openers
JP2014507455A5 (cg-RX-API-DMAC7.html)
US10023534B2 (en) Carbazole and tetrahydrocarbazole compounds useful as inhibitors of BTK
JP2010529081A5 (cg-RX-API-DMAC7.html)
CA2540768A1 (en) Pyrazolo and imidazo-pyrimidine derivatives
WO2014158916A1 (en) Substituted naphthyridine and quinoline compounds as mao inhibitors
JP2006519868A5 (cg-RX-API-DMAC7.html)
RU2015101532A (ru) Замещенные бициклические алкокси-пиразольные аналоги в качестве аллостерических модуляторов рецепторов mglur5
JP2015516429A5 (cg-RX-API-DMAC7.html)
RU2009143104A (ru) Новые двузамещенные фенилпирролидины в качестве модуляторов кортикальной катехоламинергической нейротрансмиссии
JP2013544277A5 (cg-RX-API-DMAC7.html)
JP2021524487A5 (cg-RX-API-DMAC7.html)
RU2015101512A (ru) Замещенные бициклические алкокси-пиразольные аналоги в качестве аллостерических модуляторов рецепторов mglur5
JP2019534327A5 (cg-RX-API-DMAC7.html)
AU2014302550A1 (en) Carbazole carboxamide compounds useful as kinase inhibitors
JP2023507569A5 (cg-RX-API-DMAC7.html)
JP6673218B2 (ja) ジヒドロナフタレン誘導体
JP2013542267A5 (cg-RX-API-DMAC7.html)
CN108368145A (zh) 金属络合物
JP2025502712A5 (cg-RX-API-DMAC7.html)